We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+6.46%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$81.2B
AUM Growth
+$4.94B
Cap. Flow
-$6.14B
Cap. Flow %
-7.55%
Top 10 Hldgs %
23.23%
Holding
2,627
New
307
Increased
786
Reduced
648
Closed
292

Sector Composition

Rank Sector Weight
1 Technology 19.56%
2 Healthcare 13.87%
3 Financials 13.3%
4 Industrials 12.02%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVAC
1701
DELISTED
CureVac
CVAC
$37K ﹤0.01%
3,654
+148
+4% +$1.32K
ELAN icon
1702
Elanco Animal Health
ELAN
$12.1B
$37K ﹤0.01%
3,767
+53
+1% +$492
NAN icon
1703
Nuveen New York Quality Municipal Income Fund
NAN
$369M
0
NHC icon
1704
National Healthcare
NHC
$3.43B
$37K ﹤0.01%
+611
New +$36.2K
OPY icon
1705
Oppenheimer Holdings
OPY
$1.22B
$37K ﹤0.01%
+936
New +$35.8K
SBS icon
1706
Sabesp
SBS
$18.9B
$37K ﹤0.01%
16,408
+10,437
+175% +$20.9K
BE icon
1707
Bloom Energy
BE
$67.4B
$36K ﹤0.01%
2,227
-363,892
-99% -$5.88M
HURN icon
1708
Huron Consulting
HURN
$2.39B
$36K ﹤0.01%
434
-2,022
-82% -$166K
KNSL icon
1709
Kinsale Capital Group
KNSL
$8.57B
$36K ﹤0.01%
98
LEGN icon
1710
Legend Biotech
LEGN
$3.73B
$36K ﹤0.01%
544
+18
+3% +$1.18K
NTCT icon
1711
NETSCOUT
NTCT
$2.92B
$36K ﹤0.01%
+1,191
New +$35K
PFBC icon
1712
Preferred Bank
PFBC
$1.25B
$36K ﹤0.01%
669
TRDA icon
1713
Entrada Therapeutics
TRDA
$267M
$36K ﹤0.01%
+2,417
New +$33.3K
CVSA
1714
Covista Inc
CVSA
$4.23B
$35K ﹤0.01%
+1,042
New +$41.7K
BNY
1715
DELISTED
BlackRock New York Municipal Income Trust
BNY
0
EPR icon
1716
EPR Properties
EPR
$4.7B
$35K ﹤0.01%
764
MGTX icon
1717
MeiraGTx Holdings
MGTX
$1.18B
$35K ﹤0.01%
5,336
+163
+3% +$1.05K
NBN icon
1718
Northeast Bank
NBN
$1.14B
$35K ﹤0.01%
+847
New +$32.1K
OTTR icon
1719
Otter Tail
OTTR
$3.91B
$35K ﹤0.01%
453
-205
-31% -$15.4K
VERV
1720
DELISTED
Verve Therapeutics
VERV
$35K ﹤0.01%
1,926
+55
+3% +$916
WMB icon
1721
Williams Companies
WMB
$87.8B
$35K ﹤0.01%
1,092
-1,140
-51% -$34.2K
HT
1722
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$35K ﹤0.01%
5,872
+87
+2% +$535
BUSE icon
1723
First Busey Corp
BUSE
$2.59B
$34K ﹤0.01%
+1,727
New +$33.1K
GIII icon
1724
G-III Apparel Group
GIII
$1.51B
$34K ﹤0.01%
+1,795
New +$30.9K
HE icon
1725
Hawaiian Electric Industries
HE
$2.16B
$34K ﹤0.01%
+952
New +$35.8K

Similar funds

Lazard Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Lazard Asset Management held 2,627 positions worth $81.2B, up 6.5% from $76.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Lazard Asset Management withdrew a net $6.14B in Q2 2023, closing 292 positions and reducing 648 holdings. Its most notable exit was ABB Ltd, an estimated $107M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Lazard Asset Management opened a new position in Nice worth $14.7M.

  • Lazard Asset Management's largest Q2 2023 buy was Nice: 71,266 shares worth $14.7M.
  • Lazard Asset Management added most to Exelon in Q2 2023, an estimated $410M increase.
  • Lazard Asset Management's biggest Q2 2023 reduction was Dollar General, cutting an estimated $330M.
  • Lazard Asset Management fully exited ABB Ltd in Q2 2023, selling an estimated $107M.
  • Lazard Asset Management's ten largest holdings make up 23% of its $81.2B portfolio in Q2 2023.
  • Lazard Asset Management opened 307 new positions and closed 292 in Q2 2023.
  • Lazard Asset Management's portfolio value rose 6.5% quarter-over-quarter to $81.2B.

Based on Lazard Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.